| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/06/2005 | WO2005001484A1 Method of judging the onset of periodontitis |
| 01/06/2005 | WO2005001481A1 Detection of protease-resistant prion protein following a spontaneous transformation reaction |
| 01/06/2005 | WO2005001479A1 Capacitative biosensor element and method for detecting hybridization events |
| 01/06/2005 | WO2005001477A2 Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same |
| 01/06/2005 | WO2005001416A2 High throughput assay of lp-pla2 activity |
| 01/06/2005 | WO2005001143A2 Label-free gene expression profiling with universal nanoparticle probes in microarray assay format |
| 01/06/2005 | WO2005001142A2 Methods and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 01/06/2005 | WO2005001141A2 Methods and nucleic acids for analyses of colorectal cell proliferative disorders |
| 01/06/2005 | WO2005001140A2 Methods and nucleic acids for the analysis of colon cell proliferative disorders |
| 01/06/2005 | WO2005001139A1 mRNA EXPRESSION ANALYSIS |
| 01/06/2005 | WO2005001138A2 Breast cancer survival and recurrence |
| 01/06/2005 | WO2005001137A2 Detection of high grade dysplasia in cervical cells |
| 01/06/2005 | WO2005001136A1 Methods and compositions for modulating erythropoietin expression |
| 01/06/2005 | WO2005001135A2 3’ biased detection of nucleic acids |
| 01/06/2005 | WO2005001134A1 Method for making library of defined nucleic acid molecules |
| 01/06/2005 | WO2005001132A2 Gene expression profiles that identify genetically elite ungulate mammals |
| 01/06/2005 | WO2005001131A2 Methods for diagnosing mood disorders |
| 01/06/2005 | WO2005001129A2 Mobility cassettes |
| 01/06/2005 | WO2005001128A2 Materials and methods for producing dna libraries and detecting and identifying microorganisms |
| 01/06/2005 | WO2005001127A1 P53 as an indicator of cancer risk in different ethnic groups |
| 01/06/2005 | WO2005001126A1 Detection kit for gastric cancer and metastatic gastric cancer |
| 01/06/2005 | WO2005001125A1 Method of judging mutation and polymorphism in nucleic acid |
| 01/06/2005 | WO2005001124A2 Methods of nucleic acid analysis |
| 01/06/2005 | WO2005001123A1 Dna chip based genetic typing |
| 01/06/2005 | WO2005001122A2 Electrochemical detection of dna binding |
| 01/06/2005 | WO2005001121A1 Substrates for spatially selective micron and nanometer scale deposition and combinatorial modification and fabrication |
| 01/06/2005 | WO2005001120A1 Micro and nano scale fabrication and manufacture by spatially selective deposition |
| 01/06/2005 | WO2005001119A1 Reduction of interfering peroxidase activity in peroxidase based detection methods |
| 01/06/2005 | WO2005001118A2 Detection system |
| 01/06/2005 | WO2005001115A2 Monitoring gene silencing and annotating gene function in living cells |
| 01/06/2005 | WO2005001114A2 Screening methods |
| 01/06/2005 | WO2005001113A2 Methods for detecting nucleic acid variations |
| 01/06/2005 | WO2005001111A2 Primers and probes for amplification and detection of human inhibitor of dna-binding |
| 01/06/2005 | WO2005001109A2 Methods and compositions to detect microbes in fecal samples |
| 01/06/2005 | WO2005001097A1 Method of detecting sars coronavirus |
| 01/06/2005 | WO2005001092A2 Compositions and methods for diagnosing and treating cancers |
| 01/06/2005 | WO2005001091A1 Probe set for detecting mutation and polymorphism in nucleic acid, dna array having the same immobilized thereon and method of detecting mutation and polymorphism in nucleic acid using the same |
| 01/06/2005 | WO2005001089A1 Method of detecting cancer |
| 01/06/2005 | WO2005001086A1 IMMOBILIZED mRNA-PUROMYCIN CONJUGATE AND USE THEREOF |
| 01/06/2005 | WO2005001063A2 Polynucleotides capable of target-dependent circularization and topological linkage |
| 01/06/2005 | WO2005001059A2 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 01/06/2005 | WO2005001058A2 Identification of biomarkers for liver toxicity |
| 01/06/2005 | WO2005001057A2 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/06/2005 | WO2005001052A2 Modulation of apoptosis |
| 01/06/2005 | WO2005001049A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 01/06/2005 | WO2005001046A2 Methods for predicting the course of a malignant disease |
| 01/06/2005 | WO2005001043A2 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi |
| 01/06/2005 | WO2005001034A2 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase |
| 01/06/2005 | WO2005001032A2 Fine mapping of chromosome 17 quantitative trait loci and use of same for marker assisted selection |
| 01/06/2005 | WO2005001031A2 Modulation of the rna interference pathway |
| 01/06/2005 | WO2005001030A2 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein |
| 01/06/2005 | WO2005001026A2 Adks as modifiers of the pten pathway and methods of use |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000344A2 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 01/06/2005 | WO2005000335A2 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 01/06/2005 | WO2005000200A2 Novel kinases |
| 01/06/2005 | WO2005000196A2 Inhibition of egr-1 expression by rpar-ϝ agonista and related compositions and methods |
| 01/06/2005 | WO2005000192A2 Glycogen synthase kinase-3 inhibitors |
| 01/06/2005 | WO2005000098A2 Detection methods for disorders of the lung |
| 01/06/2005 | WO2005000088A2 Expression profile of pancreatic cancer |
| 01/06/2005 | WO2005000087A2 Gene products differentially expressed in cancerous colon cells and their methods of use ii |
| 01/06/2005 | WO2004095221A8 Apparatus and methods for analyzing and characterizing nucleic acid sequences |
| 01/06/2005 | WO2004092708A3 Methods for the electrochemical detection of target compounds |
| 01/06/2005 | WO2004092213B1 Gene expressed in prostate cancer, methods and use thereof |
| 01/06/2005 | WO2004089396A3 Anti-fungal peptidomimetics |
| 01/06/2005 | WO2004085683A3 Method for early carcinoma detection and a test kit for carrying our said method |
| 01/06/2005 | WO2004082572A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 87 (gpr87) |
| 01/06/2005 | WO2004076613A3 Human nucleic acid sequences from carcinomas of the bladder |
| 01/06/2005 | WO2004075813A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii) |
| 01/06/2005 | WO2004073586A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 01/06/2005 | WO2004063334A8 Molecular cardiotoxicology modeling |
| 01/06/2005 | WO2004061076A3 Method and apparatus for determining gene expression levels |
| 01/06/2005 | WO2004058167A3 Breast specific protein expressed in cancer and methods of use thereof |
| 01/06/2005 | WO2004046726A3 Methods and kits for assays of rapid screening of diabetes |
| 01/06/2005 | WO2004019959A3 Dna repair enzymes |
| 01/06/2005 | WO2003088913A8 Peptide deformylase activated prodrugs |
| 01/06/2005 | WO2003078631A9 Novel genes |
| 01/06/2005 | WO2003056030A9 Methods and systems of nucleic acid sequencing |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2003020890A3 Genes encoding baeyer-villiger monooxygenases |
| 01/06/2005 | WO2002096923A9 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 01/06/2005 | WO2002055700A8 Human genes and gene expression products isolated from human prostate |
| 01/06/2005 | US20050005334 Herbicide tolerant cotton plants and methods for producing and identifying same peptide |
| 01/06/2005 | US20050005319 Generating conditionally lethal nicotiana or arabidopsis models for use tools in identifying preferential gene function; generating herbicide, insect and disease resistance in plants |
| 01/06/2005 | US20050005313 Using magnetic resonance imaging to identify tagged tumor marker sequences; prepariing and using antisense agents as therapeutic tools in treatment of cell proliferative disorders; immunotherapy |
| 01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |
| 01/06/2005 | US20050005311 High throughput screening for cancer genes |
| 01/06/2005 | US20050004767 Method and system for validating changes in medical practice, procedures and product choice |
| 01/06/2005 | US20050004765 Method for estimating effect of working substance and screening method |
| 01/06/2005 | US20050004350 Novel chemiluminescent reagents |
| 01/06/2005 | US20050004349 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/06/2005 | US20050004346 Recombinant anti-plasmodium falciparum antibodies |
| 01/06/2005 | US20050004324 Permselective structurally robust membrane material |
| 01/06/2005 | US20050004078 Nucleotide analogs with six-membered rings |
| 01/06/2005 | US20050004068 Modulation of tor |
| 01/06/2005 | US20050004062 Immunostimulatory oligonucleotides; activation lymphocytes; antibody therapy; anticancer agents |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004059 Gene amplification and overexpression in cancer |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |